Day: July 13, 2020

STUART, Fla., July 13, 2020 (GLOBE NEWSWIRE) — Seacoast Banking Corporation of Florida (NASDAQ: SBCF) (the “Company” or “Seacoast”) today announced it has hired Austen Carroll as executive vice president and chief lending officer. In his newly-created role, Carroll will lead the commercial banking division at Seacoast. Additionally, Julie Kleffel, the Company’s current community banking executive and central Florida market president has been promoted to chief banking officer of the Company.“Austen is a well-known and highly-regarded banker in the Southeast.  He has demonstrated tremendous success in his prior roles and will help accelerate the progression of our commercial banking business. We see great opportunity ahead and are thrilled to bring on board a leader with Austen’s talent and experience,” said Chuck Shaffer, president,...

Caris to provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trialUTRECHT, The Netherlands and CAMBRIDGE, Mass. and IRVING, Texas, July 13, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™) and Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced a collaboration to detect neuregulin 1 (NRG1) fusions in cancer patients. Under the agreement, Caris has agreed to perform whole exome sequencing of DNA and whole transcriptome sequencing of RNA for certain cancer patients, focusing on pancreatic cancer, to identify the presence ofNRG1 fusions and to increase...

HINGHAM, Mass., July 13, 2020 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced second quarter results for 2020.EarningsNet income for the quarter ended June 30, 2020 was $16,338,000 or $7.65 per share basic and $7.50 per share diluted, as compared to $8,706,000 or $4.08 per share basic and $3.99 per share diluted for the same period last year.  The Bank’s annualized return on average equity for the second quarter of 2020 was 25.28%, and the annualized return on average assets was 2.41%, as compared to 15.32% and 1.37% for the same period in 2019.  Net income per share (diluted) for the second quarter of 2020 increased by 88% over the same period in 2019. Excluding the after-tax gains and losses on securities, both realized and unrealized, core net income for the second quarter of...

GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering and, to certain investors in lieu thereof, pre-funded warrants to purchase shares of its common stock.  Altimmune also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock plus the shares of common stock underlying the pre-funded warrants sold in connection with the public offering.  All of the securities in the offering will be sold by Altimmune. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed,...

SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the closing of its previously announced underwritten public offering of 17,275,000 shares of its common stock, which includes the underwriters’ full exercise of their option to purchase additional shares and pre-funded warrants to purchase up to 4,000,000 shares of its common stock, for total gross proceeds of approximately $69.1 million, before deducting the underwriting discounts and commissions and other offering expenses payable by Otonomy. All of the securities were sold by Otonomy.Cowen and Piper Sandler acted as active joint book-running managers for the offering. Cantor Fitzgerald & Co. acted as bookrunner and H.C. Wainwright...

REDWOOD CITY, Calif., July 13, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq:RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways, today announced the closing of an underwritten public offering of 6,900,000 shares of common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions. The shares of common stock issued and sold in the offering include 900,000 shares issued upon exercise in full by the underwriters of their option to purchase additional shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution...

Companies have ongoing collaboration in first-line metastatic triple-negative breast cancerImmunomedics also announces Phase 2 NeoSTAR study in neoadjuvant triple-negative breast cancer has begun patient enrollmentMORRIS PLAINS, N.J., July 13, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced an extension of its current clinical collaboration with Roche to evaluate Trodelvy, Immunomedics’ anti-Trop-2 ADC, in combination with Tecentriq, Roche’s programmed cell death ligand 1 (PD-L1)-blocking checkpoint inhibitor (CPI), in patients with metastatic urothelial cancer (mUC) and metastatic non-small cell lung cancer (mNSCLC).“Given that Trodelvy can cause tumor-cell death with possible neoantigen...

Rogers, Arkansas , July 13, 2020 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced the opening of a new dealership located in Cabot, AR.  This will be the thirty-eighth dealership in Arkansas, the first dealership opening in fiscal year 2021 and our 149th dealership.  The dealership will be managed by Dennis Johnson, with the assistance of Chris Martin.  This will be the second dealership managed by Mr. Johnson as we look to expand the number of customers served by our top performing general managers.“A great deal of thought and foresight is placed on our decisions about where to grow. We select communities where we believe we can fill a void when it comes to what we offer at Car-Mart,” said Jeff Williams, President and Chief Executive Officer, “We’re different from traditional dealerships. In addition to...

WESTCHESTER, Ill., July 13, 2020 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its 2020 second quarter financial results for the period ended June 30, 2020, before the market opens on Tuesday, August 4, 2020.Jim Zallie, president and chief executive officer, and James Gray, executive vice president and chief financial officer, will host a conference call on August 4 at 8 a.m. CT to discuss the Company’s financial performance. The conference call and accompanying slide presentation will be webcast live at https://ir.ingredionincorporated.com/events-and-presentations. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the presentation. A replay of the presentation will be available...

LAS VEGAS, July 13, 2020 (GLOBE NEWSWIRE) — TOGA LIMITED (OTC: TOGL) (“Toga” or the “Company”) is pleased to announce that it has engaged Marcum LLP as its new independent registered public accounting firm to replace Pinnacle Accountancy Group of Utah.  The change of the Company’s independent registered public accounting firm was approved by the Audit Committee of its Board of Directors on July 10, 2020Contact:Alexander D. HendersonTOGA LIMITED2575 McCabe Way, Suite 100Irvine, CA 92614(949) 333-1603